advertisement

Topcon

Molecular medicine reports 10

Showing records 1 to 10 | Display all abstracts in Molecular medicine reports

80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Jia Y
Molecular medicine reports 2019; 19: 4863-4871
81103 Identification of pathogenic genes and transcription factors in glaucoma
Feng J
Molecular medicine reports 2019; 20: 216-224
80534 miR‑17‑5p regulates the proliferation and apoptosis of human trabecular meshwork cells by targeting phosphatase and tensin homolog
Wang X; Li Z
Molecular medicine reports 2019; 19: 3132-3138
80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Jiang S
Molecular medicine reports 2019; 19: 4863-4871
81103 Identification of pathogenic genes and transcription factors in glaucoma
Xu J
Molecular medicine reports 2019; 20: 216-224
80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Chen C
Molecular medicine reports 2019; 19: 4863-4871
80534 miR‑17‑5p regulates the proliferation and apoptosis of human trabecular meshwork cells by targeting phosphatase and tensin homolog
Bai J
Molecular medicine reports 2019; 19: 3132-3138
80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Lu G
Molecular medicine reports 2019; 19: 4863-4871
80534 miR‑17‑5p regulates the proliferation and apoptosis of human trabecular meshwork cells by targeting phosphatase and tensin homolog
Song W; Zhang F
Molecular medicine reports 2019; 19: 3132-3138
80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Xie Y; Sun X; Huang L
Molecular medicine reports 2019; 19: 4863-4871

Issue 20-3

Change Issue


advertisement

Oculus